Details for 2016745005

Up to date per 03.04.2026

Actions

Title / Product Name

CHK1/2-INHIBITOREN ZUR BEHANDLUNG VON NEUROBLASTOMEN UND/ODER WEICHGEWEBESARKOMEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016745005

EP Publication Number

3325468

E-Number

1333358

Language

PCT Number

US16042529

Publication Date

30.05.2018 A

11.11.2020 B1

Registration Date

11.11.2020

AT Publication Date

15.11.2020

Application Date

15.07.2016

Registration Number

Priorities

23.07.2015

201562196087 P

30.10.2015

201562248408 P

07.12.2015

201562264059 P

IPC

C07D 403/12 20060101AFI20170201BHEP

Maximum Duration of Protection

15.07.2036

Owner

Eli Lilly and CompanyLilly Corporate Center Indianapolis, IN 46285US

Representative

No representatives present

Inventor

STANCATO, Louis Frankc/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288US